Apellis Pharmaceuticals IncのROIC
Apellis Pharmaceuticals IncのROICは何ですか。
Apellis Pharmaceuticals IncのROICは-64.16%です。
ROICの定義は何ですか。
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
NASDAQのセクタHealth CareにおけるROICの企業と比べるApellis Pharmaceuticals Inc
Apellis Pharmaceuticals Incは何をしますか。
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Apellis Pharmaceuticals Incと類似のroic
- Gritstone Bio IncのROICは-64.25%です。
- POET TechnologiesのROICは-64.23%です。
- Interconnect VenturesのROICは-64.21%です。
- Marathon PatentのROICは-64.18%です。
- Skeena ResourcesのROICは-64.18%です。
- TransphormのROICは-64.17%です。
- Apellis Pharmaceuticals IncのROICは-64.16%です。
- Professional Diversity NetworkのROICは-64.13%です。
- Atomo DiagnosticsのROICは-64.10%です。
- GeneNewsのROICは-64.08%です。
- Dragon Victory International LtdのROICは-64.05%です。
- OzAurum ResourcesのROICは-64.03%です。
- STARAMBA SEのROICは-64.01%です。